Clinical Trials Logo
  1. Home
  2. Cancer
  3. NCT05493150
  4. Details
NCT05493150 Clinical Trial

Antalgic Effects of Well-being Treatments in Cancer Care

Cancer Clinical Trial

— Well Being  

Official title:
Antalgic Effects of Well-being Treatments in Cancer Care; Foot Reflexology, Socio-aesthetics, Sophrology, Singing

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT05493150
Other study ID # 00006
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 22, 2020
Est. completion date December 30, 2021

Study information
Verified date August 2022
Source Centre Hospitalier de Valence
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

observational , Monocentric, study to assess antalgic effects of well-being treatment in cancer care.

Description:

Contrary to supportive care, well-being care is imperfectly assessed. Well being care (WBC) consist on complementary programs, with no real consensus. Very few studies have rigorously evaluated its benefits The objective of this study was to evaluate the impact of four well-being treatments (foot reflexology, socio-aesthetics, Sophrology and singing) provided in a healthcare facility

Recruitment information / eligibility
Status Completed
Enrollment 180
Est. completion date December 30, 2021
Est. primary completion date September 30, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - all type of cancer treated at the general Hospital of Valence - patient agree to participate on Well being session: foot reflexology, socio-aesthetics, Sophrology and singing - Age = 18 years - Affiliation to a Social security system - Patient who has given written consent signed before any specific procedure of the protocol Exclusion Criteria: - Patient under guardianship, deprived of liberty, safeguard of justice - Patient presenting a serious psychiatric pathology that does not allow compliance with the completion of the scale (at the discretion of the investigator) - Refusal to participate in research

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
France Ch Valence Valence Drome

Sponsors (1)
Lead Sponsor Collaborator
Centre Hospitalier de Valence

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary Pain assesment numerical scale 0 to 10, with 0 being "no pain" and 10 being "the worst pain imaginable." 1 immediately before well being treatment
Primary Pain assesment numerical scale 0 to 10, with 0 being "no pain" and 10 being "the worst pain imaginable." 1 immediately after well being treatment
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients